| Name | Cascadia Of Boise |
|---|---|
| Location | 6000 W Denton St, Boise, Idaho |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 99 |
| Occupancy Rate | 58.89% |
| Medicare ID (CCN) | 135146 |
| Legal Business Name | Boise Of Cascadia Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1295249241 |
| Organization Name | BOISE OF CASCADIA, LLC |
| Doing Business As | CASCADIA OF BOISE |
| Address | 6000 W. Denton St., Boise, ID 83706 |
| Phone Number | 208-401-9600 |
News Archive
A genetic disorder that affects about 1 in every 2,500 births can cause a bewildering array of clinical problems, including brain tumors, impaired vision, learning disabilities, behavioral problems, heart defects and bone deformities. The symptoms and their severity vary among patients affected by this condition, known as neurofibromatosis type 1 (NF1).
Over the last six years a group of Estonian geneticists led by Associate Professor Agne Velthut-Meikas and a PhD student Ilmatar Rooda from TalTech Department of Chemistry and Biotechnology have studied genes previously associated primarily with female hormone synthesis and ovarian follicle development.
The Spanish Head and Neck Cancer Cooperative Group (TTCC) announced today that Induction Chemotherapy (IC) delivered prior to standard ChemoRadiotherapy (CRT), a treatment paradigm defined as sequential therapy, compared to upfront CRT alone, significantly prolonged Time-to-Treatment Failure (TTF) for patients with unresectable Locally Advanced Head and Neck Cancer (LAHNC).
The Association of Clinical Research Organizations (ACRO), which represents the global leaders in clinical outsourcing, today released the following statement in recognition of World Heart Day.
RSV, a virus that causes respiratory infections in infants and young children, selectively kills cancer cells while leaving healthy cells alone, researchers from the School of Medicine at The University of Texas Health Science Center San Antonio said.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A genetic disorder that affects about 1 in every 2,500 births can cause a bewildering array of clinical problems, including brain tumors, impaired vision, learning disabilities, behavioral problems, heart defects and bone deformities. The symptoms and their severity vary among patients affected by this condition, known as neurofibromatosis type 1 (NF1).
Over the last six years a group of Estonian geneticists led by Associate Professor Agne Velthut-Meikas and a PhD student Ilmatar Rooda from TalTech Department of Chemistry and Biotechnology have studied genes previously associated primarily with female hormone synthesis and ovarian follicle development.
The Spanish Head and Neck Cancer Cooperative Group (TTCC) announced today that Induction Chemotherapy (IC) delivered prior to standard ChemoRadiotherapy (CRT), a treatment paradigm defined as sequential therapy, compared to upfront CRT alone, significantly prolonged Time-to-Treatment Failure (TTF) for patients with unresectable Locally Advanced Head and Neck Cancer (LAHNC).
The Association of Clinical Research Organizations (ACRO), which represents the global leaders in clinical outsourcing, today released the following statement in recognition of World Heart Day.
RSV, a virus that causes respiratory infections in infants and young children, selectively kills cancer cells while leaving healthy cells alone, researchers from the School of Medicine at The University of Texas Health Science Center San Antonio said.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 15.03 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.17 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 60.95 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.7 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.74 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 9.88 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0.52 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.08 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 82.81 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 21.43 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 76.94 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 4.35 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 36.45 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 17.32 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.64 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.43 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 68.4 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 83.59 | 82.93 |
News Archive
A genetic disorder that affects about 1 in every 2,500 births can cause a bewildering array of clinical problems, including brain tumors, impaired vision, learning disabilities, behavioral problems, heart defects and bone deformities. The symptoms and their severity vary among patients affected by this condition, known as neurofibromatosis type 1 (NF1).
Over the last six years a group of Estonian geneticists led by Associate Professor Agne Velthut-Meikas and a PhD student Ilmatar Rooda from TalTech Department of Chemistry and Biotechnology have studied genes previously associated primarily with female hormone synthesis and ovarian follicle development.
The Spanish Head and Neck Cancer Cooperative Group (TTCC) announced today that Induction Chemotherapy (IC) delivered prior to standard ChemoRadiotherapy (CRT), a treatment paradigm defined as sequential therapy, compared to upfront CRT alone, significantly prolonged Time-to-Treatment Failure (TTF) for patients with unresectable Locally Advanced Head and Neck Cancer (LAHNC).
The Association of Clinical Research Organizations (ACRO), which represents the global leaders in clinical outsourcing, today released the following statement in recognition of World Heart Day.
RSV, a virus that causes respiratory infections in infants and young children, selectively kills cancer cells while leaving healthy cells alone, researchers from the School of Medicine at The University of Texas Health Science Center San Antonio said.
› Verified 7 days ago
Avamere Transitional Care & Rehabilitation - Boise Location: 1001 South Hilton Street, Boise, Idaho 83705 Phone: (208) 345-4464 | |
Valley View Nursing & Rehabilitation Location: 1140 North Allumbaugh Street, Boise, Idaho 83704 Phone: (208) 854-8500 | |
St Luke's Rehab - Elks Sub Acute Rehab Unit Location: 600 North Robbins Road, Boise, Idaho 83702 Phone: (208) 489-4444 |